Pharmacoeconomic impact of use of the probiotic Lactobacillus reuteri DSM 17938 for prevention of necrotizing enterocolitis in extremely low-birth-weight infants

• Váldodahkkit: Dimaguila MAVT (Dahkki), Gal P (Dahkki), Wilson T (Dahkki), Wimmer Jr JE (Dahkki), Smith M (Dahkki), Carlos RQ (Dahkki), Davanzo CC (Dahkki), Ransom JL (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Dove Medical Press, 2013-04-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Mary Ann VT Dimaguila,1,2 Peter Gal,1,3,4 Tiffany Wilson,1 John E Wimmer Jr,1,2 McCrae Smith,1,2 Rita Q Carlos,1,2 Christie C Davanzo,1,2 J Laurence Ransom1,2 1Women's Hospital of Greensboro, Cone Health, Greensboro, NC, USA; 2Piedmont Neonatology, Greensboro, NC, USA; 3Eshelman School of Ph...